These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21946722)

  • 41. Call to consolidate achievements for onchocerciasis and lymphatic filariasis control.
    Hoerauf A; Walter RD; Remme H; Lazdins J; Fleischer B
    Trends Parasitol; 2001 Dec; 17(12):566-7. PubMed ID: 11756020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2009 Oct; 84(42):437-44. PubMed ID: 19860021
    [No Abstract]   [Full Text] [Related]  

  • 43. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2010 Sep; 85(38):365-72. PubMed ID: 20853547
    [No Abstract]   [Full Text] [Related]  

  • 44. Lymphatic filariasis and Brugia timori: prospects for elimination.
    Fischer P; Supali T; Maizels RM
    Trends Parasitol; 2004 Aug; 20(8):351-5. PubMed ID: 15246315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Filariasis elimination, Zanzibar.
    Wkly Epidemiol Rec; 2001 Dec; 76(51-52):406-8. PubMed ID: 11789061
    [No Abstract]   [Full Text] [Related]  

  • 46. Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement.
    Wkly Epidemiol Rec; 2012 Nov; 87(48):478-82. PubMed ID: 23213667
    [No Abstract]   [Full Text] [Related]  

  • 47. Global programme to eliminate lymphatic filariasis: progress report, 2011.
    Wkly Epidemiol Rec; 2012 Sep; 87(37):346-56. PubMed ID: 22977953
    [No Abstract]   [Full Text] [Related]  

  • 48. Translating Research into Reality: Elimination of Lymphatic Filariasis from Haiti.
    Lammie PJ; Eberhard ML; Addiss DG; Won KY; Beau de Rochars M; Direny AN; Milord MD; Lafontant JG; Streit TG
    Am J Trop Med Hyg; 2017 Oct; 97(4_Suppl):71-75. PubMed ID: 29064364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymphatic filariasis: constraints ahead.
    Mishra CP; Singh N
    Indian J Public Health; 2003; 47(1):27-30. PubMed ID: 14723292
    [No Abstract]   [Full Text] [Related]  

  • 50. Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration.
    Cabral S; Bonfim C; Oliveira R; Oliveira P; Guimarães T; Brandão E; Aguiar-Santos AM; Medeiros Z
    Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e23. PubMed ID: 28443941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
    Nandha B; Krishnamoorthy K; Jambulingam P
    Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions.
    Michael E; Malecela-Lazaro MN; Maegga BT; Fischer P; Kazura JW
    Trends Parasitol; 2006 Nov; 22(11):529-35. PubMed ID: 16971182
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Global Programme to Eliminate Lymphatic Filariasis.
    Wkly Epidemiol Rec; 2006 Jun; 81(22):221-32. PubMed ID: 16749186
    [No Abstract]   [Full Text] [Related]  

  • 54. Lymphatic filariasis.
    Manokaran G
    Lymphology; 2005 Jun; 38(2):105. PubMed ID: 16184820
    [No Abstract]   [Full Text] [Related]  

  • 55. Global programme to eliminate lymphatic filariasis: progress report for 2012.
    Wkly Epidemiol Rec; 2013 Sep; 88(37):389-99. PubMed ID: 24073461
    [No Abstract]   [Full Text] [Related]  

  • 56. Lymphatic filariasis: patients and the global elimination programme.
    Mackenzie CD; Lazarus WM; Mwakitalu ME; Mwingira U; Malecela MN
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S41-51. PubMed ID: 19843397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A great success in lymphatic filariasis control in China. National Technical Steering Group for Filariasis Control and Research, MOPH.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):81-5. PubMed ID: 7554168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka.
    Gunawardena GS; Ismail MM; Bradley MH; Karunaweera ND
    Ann Trop Med Parasitol; 2007 Jun; 101(4):335-41. PubMed ID: 17524248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The sharp end - experiences from the Tanzanian programme for the elimination of lymphatic filariasis: notes from the end of the road.
    Malecela MN; Mwingira U; Mwakitalu ME; Kabali C; Michael E; Mackenzie CD
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S53-7. PubMed ID: 19843398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration.
    Derua YA; Kisinza WN; Simonsen PE
    Parasit Vectors; 2018 Jul; 11(1):429. PubMed ID: 30029675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.